These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 12562449)

  • 1. Symptomatic response to lansoprazole predicts abnormal acid reflux in endoscopy-negative patients with non-cardiac chest pain.
    Xia HH; Lai KC; Lam SK; Hu WH; Wong NY; Hui WM; Lau CP; Chen WH; Chan CK; Wong WM; Wong BC
    Aliment Pharmacol Ther; 2003 Feb; 17(3):369-77. PubMed ID: 12562449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of an empirical trial of high-dose lansoprazole on symptom response of patients with non-cardiac chest pain--a randomized, double-blind, placebo-controlled, crossover trial.
    Bautista J; Fullerton H; Briseno M; Cui H; Fass R
    Aliment Pharmacol Ther; 2004 May; 19(10):1123-30. PubMed ID: 15142202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of a therapeutic trial of high-dose rabeprazole on symptom response of patients with non-cardiac chest pain: a randomized, double-blind, placebo-controlled, crossover trial.
    Dickman R; Emmons S; Cui H; Sewell J; Hernández D; Esquivel RF; Fass R
    Aliment Pharmacol Ther; 2005 Sep; 22(6):547-55. PubMed ID: 16167971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laparoscopic fundoplication versus lansoprazole for gastro-oesophageal reflux disease. A pH-metric comparison.
    Frazzoni M; Grisendi A; Lanzani A; Melotti G; De Micheli E
    Dig Liver Dis; 2002 Feb; 34(2):99-104. PubMed ID: 11926567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nutcracker oesophagus: a double-blind, placebo-controlled, cross-over study of the effects of lansoprazole.
    Borjesson M; Rolny P; Mannheimer C; Pilhall M
    Aliment Pharmacol Ther; 2003 Dec; 18(11-12):1129-35. PubMed ID: 14653833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical trial: chest pain caused by presumed gastro-oesophageal reflux in coronary artery disease - controlled study of lansoprazole vs. placebo.
    Talwar V; Wurm P; Bankart MJ; Gershlick AH; de Caestecker JS
    Aliment Pharmacol Ther; 2010 Jul; 32(2):191-9. PubMed ID: 20456303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Speed of onset of oesophageal acid reduction with different proton-pump inhibitors in patients with reflux oesophagitis.
    Newton M; Burnham WR; Kamm MA
    Eur J Gastroenterol Hepatol; 1998 Sep; 10(9):753-8. PubMed ID: 9831269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lansoprazole vs. omeprazole for gastro-oesophageal reflux disease: a pH-metric comparison.
    Frazzoni M; De Micheli E; Grisendi A; Savarino V
    Aliment Pharmacol Ther; 2002 Jan; 16(1):35-9. PubMed ID: 11856076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid symptom relief in reflux oesophagitis: a comparison of lansoprazole and omeprazole.
    Mee AS; Rowley JL
    Aliment Pharmacol Ther; 1996 Oct; 10(5):757-63. PubMed ID: 8899084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnosis of gastroesophageal reflux disease-related noncardiac chest pain].
    Zheng J; Du ZM; Chen MH; Lin JK; Hu PJ
    Zhonghua Yi Xue Za Zhi; 2008 May; 88(20):1390-3. PubMed ID: 18953876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of ambulatory 24-hour esophageal pH monitoring results with symptom improvement in patients with noncardiac chest pain due to gastroesophageal reflux disease.
    Fass R; Fennerty MB; Johnson C; Camargo L; Sampliner RE
    J Clin Gastroenterol; 1999 Jan; 28(1):36-9. PubMed ID: 9916663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short course of omeprazole: a better first diagnostic approach to noncardiac chest pain than endoscopy, manometry, or 24-hour esophageal pH monitoring.
    Pandak WM; Arezo S; Everett S; Jesse R; DeCosta G; Crofts T; Gennings C; Siuta M; Zfass A
    J Clin Gastroenterol; 2002 Oct; 35(4):307-14. PubMed ID: 12352293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose proton-pump inhibitors as a diagnostic test of gastro-oesophageal reflux disease in endoscopic-negative patients.
    Juul-Hansen P; Rydning A; Jacobsen CD; Hansen T
    Scand J Gastroenterol; 2001 Aug; 36(8):806-10. PubMed ID: 11495074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hiatal hernia is the key factor determining the lansoprazole dosage required for effective intra-oesophageal acid suppression.
    Frazzoni M; De Micheli E; Grisendi A; Savarino V
    Aliment Pharmacol Ther; 2002 May; 16(5):881-6. PubMed ID: 11966495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors for relapse of reflux oesophagitis and symptoms during 12 months of therapy with lansoprazole.
    Hatlebakk JG; Berstad A
    Aliment Pharmacol Ther; 1997 Dec; 11(6):1093-9. PubMed ID: 9663835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of omeprazole, lansoprazole and pantoprazole in the maintenance treatment of severe reflux oesophagitis.
    Jaspersen D; Diehl KL; Schoeppner H; Geyer P; Martens E
    Aliment Pharmacol Ther; 1998 Jan; 12(1):49-52. PubMed ID: 9692700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laryngopharyngeal reflux: prospective cohort study evaluating optimal dose of proton-pump inhibitor therapy and pretherapy predictors of response.
    Park W; Hicks DM; Khandwala F; Richter JE; Abelson TI; Milstein C; Vaezi MF
    Laryngoscope; 2005 Jul; 115(7):1230-8. PubMed ID: 15995512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective intra-oesophageal acid suppression in patients with gastro-oesophageal reflux disease: lansoprazole vs. pantoprazole.
    Frazzoni M; De Micheli E; Grisendi A; Savarino V
    Aliment Pharmacol Ther; 2003 Jan; 17(2):235-41. PubMed ID: 12534408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lansoprazole compared with ranitidine for the treatment of nonerosive gastroesophageal reflux disease.
    Richter JE; Campbell DR; Kahrilas PJ; Huang B; Fludas C
    Arch Intern Med; 2000 Jun; 160(12):1803-9. PubMed ID: 10871974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endoscopy-negative reflux disease: what is the value of a proton-pump inhibitor test in everyday clinical practice?
    Juul-Hansen P; Rydning A
    Scand J Gastroenterol; 2003 Dec; 38(12):1200-3. PubMed ID: 14750637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.